Citations

Citations to this article as recorded by  

• Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review
  Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto
  Liver International.2024; 44(5): 1075.     CrossRef
• The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis
  Bing Chen, Umair Iqbal, Shivani K. Desai, Jacob Gries, Elijah Verheyen, Mengdan Xie, Maan El Halabi, Sara Gaines, Ilan Weisberg
  Journal of Viral Hepatitis.2024; 31(10): 633.     CrossRef
• Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients
  Doaa Mohamed Abdelnajid, Ahmed Y. Elmowafy, Lionel Rostaing, Marwa T. Elrakaiby
  Medicine.2023; 102(28): e34125.     CrossRef
• Hypoglycemia associated with direct‐acting anti‐hepatitis C virus drugs: An epidemiologic surveillance study of the FDA adverse event reporting system (FAERS)
  Yu Zhou, Wenhuo Xie, Chenhua Zheng, Libin Liu, Zhou Chen, Xiaolu Wang
  Clinical Endocrinology.2022; 96(5): 690.     CrossRef
• Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response
  Sara Cuesta-Sancho, Mercedes Márquez-Coello, Francisco Illanes-Álvarez, Denisse Márquez-Ruiz, Ana Arizcorreta, Fátima Galán-Sánchez, Natalia Montiel, Manuel Rodriguez-Iglesias, José-Antonio Girón-González
  World Journal of Hepatology.2022; 14(1): 62.     CrossRef
• Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?
  Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto
  Biomedicines.2022; 10(3): 534.     CrossRef
• Hépatite B et C: une mise à jour sur lʼhépatite virale chronique
  Marie Ongaro, Francesco Negro
  Schweizer Gastroenterologie.2022; 3(1): 19.     CrossRef
• Effect of achieving sustained virological response with direct-acting antiviral agents on glycemic control in diabetic patients with chronic hepatitis C infection
  Mohamed El-Kassas, Runia El-Folly, Maram Aboromia, Heba Aly, Mohamed Bahgat, Mostafa Hamed
  Egyptian Liver Journal.2022;[Epub]     CrossRef
• Hepatitis C virus infection and diabetes: A complex bidirectional relationship
  Stefano Ciardullo, Alessandro Mantovani, Antonio Ciaccio, Marco Carbone, Pietro Invernizzi, Gianluca Perseghin
  Diabetes Research and Clinical Practice.2022; 187: 109870.     CrossRef
• Does Hepatitis C Virus Treatment by Directly Acting Antivirals Obligate Shifting Patients with Type 2 Diabetes from Oral Hypoglycemic Drugs to Insulin Therapy?
  Rasha Youssef Hagag, Ahmed Fawzy Selim, Omneya Darrag, Hassan Zied, Mohamed Sabry Aboelnasr
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1261.     CrossRef
• Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals
  Nehal K. Abdel Fattah, Sara M. Shaheen, Osama A. Ahmed, Kadry Elsaeed, Nagwa A. Sabri
  F1000Research.2022; 11: 649.     CrossRef
• Hepatitis C virus, insulin resistance, and diabetes: A review
  Nabeel Alzahrani
  Microbiology and Immunology.2022; 66(10): 453.     CrossRef
• The Extent of Insulin Resistance in Patients That Cleared Viral Hepatitis C Infection and the Role of Pre-Existent Type 2 Diabetes Mellitus: A Meta-Analysis
  Marian-Sorin Popescu, Andrei Ioan Drocas, Andrei Osman, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Daniel-Cristian Pîrvu, Radu Mitruț, Dragoș Nicolae Mărgăritescu, Antonia Radu, Daniela Calina, Anca Oana Docea, Paul Mitruț
  Reports.2022; 5(4): 42.     CrossRef
• Global longitudinal strain as a predictor of short-term effect of oral antiviral regimens on myocardium in Egyptian patients with chronic viral hepatitis C
  Hazem Mohammad-Ali Farrag, Mina Samir Monir, Wael Soliman Abdel-Dayem, Hisham Abdel-Haleem Ali, Alaa Mohammad Ibrahim
  The Egyptian Heart Journal.2021;[Epub]     CrossRef
• Residual risk of liver disease after hepatitis C virus eradication
  Francesco Negro
  Journal of Hepatology.2021; 74(4): 952.     CrossRef
• Extrahepatic Manifestations of Chronic HCV Infection
  Dan L. Longo, Patrice Cacoub, David Saadoun
  New England Journal of Medicine.2021; 384(11): 1038.     CrossRef
• Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents
  Sergio Estefan, Carlos Eduardo Brandão-Melo, Cintia Marques dos Santos Silva, Danilo Cosme Klein Gomes, Paula Cardoso, Marcia Helena S. Costa
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Current situation of viral hepatitis in Egypt
  Ashraf Elbahrawy, Marwa K. Ibrahim, Ahmed Eliwa, Mohamed Alboraie, Ali Madian, Hussein Hassan Aly
  Microbiology and Immunology.2021; 65(9): 352.     CrossRef
• The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis C
  Marco SACCO, Giorgio M. SARACCO
  Minerva Gastroenterology.2021;[Epub]     CrossRef
• The impact of HCV eradication on hyperglycemia, insulin resistance, cytokine production, and insulin receptor substrate-1 and 2 expression in patients with HCV infection
  Basant Mahmoud, Adel Abdel Moneim, Doaa Mabrouk
  Clinical and Experimental Medicine.2021; 22(4): 583.     CrossRef
• Systematic review: chronic viral hepatitis and metabolic derangement
  Chia‐Chi Wang, Pin‐Nan Cheng, Jia‐Horng Kao
  Alimentary Pharmacology & Therapeutics.2020; 51(2): 216.     CrossRef
• Effect of treatment with direct antiviral agents (DAAs) on glycemic control in patients with type 2 diabetes mellitus & hepatitis C virus genotype 4
  Hassan Yousef Zied, Nashwa Mohamed Abo Alnasr, Amal Said El-Bendary, Sherief Abd-Elsalam, Rasha Youssef Hagag
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(4): 679.     CrossRef
• Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
  Pradeep Kumar Mada, Matthew E. Malus, Arvin Parvathaneni, Bing Chen, Gabriel Castano, Sharon Adley, Maureen Moore, Michinari Hieda, Mohammed J. Alam, Mark Feldman, John William King
  International Journal of Hepatology.2020; 2020: 1.     CrossRef
• Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments
  Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier
  Clinical Science.2020; 134(16): 2117.     CrossRef
• Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic Control
  Jennifer Andres, Michael Barros, Michael Arutunian, Huaqing Zhao
  Journal of Managed Care & Specialty Pharmacy.2020; 26(6): 775.     CrossRef
• Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy
  Francesco Negro
  Cold Spring Harbor Perspectives in Medicine.2020; 10(4): a036921.     CrossRef
• The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm
  Davide Giuseppe Ribaldone, Marco Sacco, Giorgio Maria Saracco
  Journal of Clinical Medicine.2020; 9(2): 563.     CrossRef
• Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
  Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi
  JGH Open.2020; 4(4): 713.     CrossRef
• Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
  Mohamed Mohei El Badry, Doaa Abdelhady Ali, Noha Hamdy Eltaweel, Marwa A. Abdel-Wahed
  Egyptian Liver Journal.2020;[Epub]     CrossRef
• Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis
  Kamolyut Lapumnuaypol, David Pisarcik, Prapaipan Putthapiban, Weera Sukhumthammarat, Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert
  Indian Journal of Medical Research.2020; 152(6): 562.     CrossRef
• Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXI
  Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana
  Revista Colombiana de Gastroenterología.2019; 34(3): 277.     CrossRef
• Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients
  Giacomo Gastaldi, Diana Gomes, Philippe Schneiter, Xavier Montet, Luc Tappy, Sophie Clément, Francesco Negro, Jee-Fu Huang
  PLOS ONE.2019; 14(6): e0217751.     CrossRef
• The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis
  Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina
  Acta Diabetologica.2019; 56(3): 341.     CrossRef
• Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy
  Amir Gilad, Zachary P. Fricker, Adam Hsieh, Dylan D. Thomas, Toni Zahorian, David P. Nunes
  Journal of Clinical Gastroenterology.2019; 53(8): 616.     CrossRef
• Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
  Teegan R. Lim, Jonathan M. Hazlehurst, Andrei I. Oprescu, Matthew J. Armstrong, Sewa F. Abdullah, Nigel P. Davies, Robert Flintham, Peter Balfe, David J. Mutimer, Jane A. McKeating, Jeremy W. Tomlinson
  Clinical Endocrinology.2019; 90(3): 440.     CrossRef
• Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis
  Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio
  Journal of Viral Hepatitis.2019; 26(11): 1249.     CrossRef
• Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
  Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic disease
  Zobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis
  Journal of Viral Hepatitis.2018; 25(S3): 6.     CrossRef
• Poor Glycemic Control and Abrupt Onset of Diabetes in HCV Patients Receiving direct-acting Antiviral Drugs: Case Series
  Braira Wahid, Muhammad Wasim, Komal Saleem, Muhammad Waqar, Sajjad, Khansa Wahid, Manzoor Hussain, Muhammad Idrees
  Future Virology.2018; 13(8): 525.     CrossRef
• Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort
  A. Provoost, M. Dramé, L. Cotte, L. Cuzin, R. Garraffo, D. Rey, F. Raffi, I. Poizot‐Martin, P. Pugliese, F. Bani‐Sadr
  Alimentary Pharmacology & Therapeutics.2018; 48(3): 281.     CrossRef
• The effect of sustained virological response by direct-acting antivirals on insulin resistance and diabetes mellitus in patients with chronic hepatitis C
  Luigi Elio Adinolfi, Luca Rinaldi, Aldo Marrone, Mauro Giordano
  Expert Review of Anti-infective Therapy.2018; 16(8): 595.     CrossRef
• Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
  Sylvia Drazilova, Martin Janicko, Lubomir Skladany, Pavol Kristian, Marian Oltman, Maria Szantova, Dusan Krkoska, Eva Mazuchova, Lubica Piesecka, Veronika Vahalova, Marek Rac, Ivan Schreter, Ladislav Virag, Tomas Koller, Adriana Liptakova, Miriam Ondrasov
  Canadian Journal of Gastroenterology and Hepatology.2018; 2018: 1.     CrossRef
• INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES
  Vanessa Gutierrez de ANDRADE, Fábio da Silva YAMASHIRO, Cássio Vieira OLIVEIRA, Alecsandro MOREIRA, Fernanda Cristina WINCKLER, Giovanni Faria SILVA
  Arquivos de Gastroenterologia.2018; 55(3): 274.     CrossRef
• Expert Opinion on Managing Chronic HCV Infection in Patients with Type 2 Diabetes Mellitus
  Luigi Elio Adinolf, Ira Jacobson, Mark Bondin, Patrice Cacoub
  Antiviral Therapy.2018; 23(1_suppl): 11.     CrossRef